PANBELA THERAPEUTICS INC (PBLA) Stock Balance Sheet
USA - NASDAQ:PBLA - US69833W4042 - Common Stock
1.11 USD
-0.12 (-9.76%)
1.04 USD
-0.07 (-6.31%)
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | 9.02M | 2.45M | |||
| Cash Equivalents | 910.00K | 1.29M | 11.87M | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | 160.00K | 50.00K | 320.00K | 320.00K | 360.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 820.00K | 440.00K | 90.00K | 410.00K | 280.00K | |||
| Total Current Assets | 1.89M | 1.78M | 12.28M | 9.76M | 3.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | null | null | null | null | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 8.74M | 3.20M | 590.00K | 60.00K | 50.00K | |||
| Total Non-Current Assets | 8.74M | 3.20M | 590.00K | 50.00K | 50.00K | |||
| TOTAL ASSETS | 10.63M | 4.98M | 12.87M | 9.81M | 3.14M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 650.00K | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 1.00M | 1.00M | null | 0 | 860.00K | |||
| Accrued Expenses | 1.31M | 3.32M | 2.02M | 810.00K | 300.00K | |||
| Accounts Payable | 6.61M | 2.87M | 640.00K | 550.00K | 600.00K | |||
| Other Current Liabilities | null | null | null | null | null | |||
| Total Current Liabilities | 8.92M | 7.83M | 2.66M | 1.37M | 1.76M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.19M | 5.19M | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | null | null | |||
| Total Non-Current Liabilities | 4.19M | 5.20M | 0 | 0 | 0 | |||
| TOTAL LIABILITIES | 13.11M | 13.03M | 2.66M | 1.37M | 1.76M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -109.88M | -91.09M | -56.16M | -46.03M | -41.26M | |||
| Additional Paid In Capital | 106.03M | 82.29M | 66.23M | 54.85M | 42.33M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 0 | 0 | 10.00K | 10.00K | 10.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 1.37M | 760.00K | 130.00K | -380.00K | 310.00K | |||
| Shares Outstanding | 3.00M | 30.00K | 10.00K | 10.00K | 10.00K | |||
| Tangible Book Value per Share | -0.8267 | -268.3333 | 1.02K | 845 | 139 | |||
| Total Shareholders' Equity | -2.48M | -8.05M | 10.21M | 8.45M | 1.39M | |||
| TOTAL LIABILITIES AND EQUITY | 10.63M | 4.98M | 12.87M | 9.81M | 3.14M | |||
| Statistics | ||||||||
| Debt/Equity | -1.69 | -0.73 | N/A | N/A | N/A | |||
| Current Ratio | 0.21 | 0.23 | 4.62 | 7.12 | 1.76 | |||
| Return On Assets (ROA) | -221.35% | -701.41% | -78.79% | -48.62% | -197.45% | |||
| Return On Equity (ROE) | N/A | N/A | -99.31% | -56.45% | -446.04% | |||
All data in USD , ROIC based on taxRate of 0.21